AstraZeneca is a global, science-led pharmaceutical business committed to excellence in research, development and commercialisation of prescription medicines. The company focuses on Oncology, aiming to eliminate cancer as a cause of death; BioPharmaceuticals, targeting chronic diseases to protect vital organs and achieve remission; and Rare Disease, advancing medicines for conditions with significant unmet medical need. With 197 pipeline projects and 16 blockbuster medicines, AstraZeneca transforms patient outcomes through innovation and collaboration. Its 96,100 employees across six global R&D centres invest $14.2bn annually in science, pushing boundaries to deliver improved outcomes and better quality of life for patients worldwide.
96100
Team Members
1999
Founded
Pharma
Sector
Hybrid
Work Environment
A world where science eliminates cancer as a cause of death, reverses chronic disease progression, and delivers breakthrough treatments for rare conditions with unmet medical need, transforming healthcare for billions of people globally.
We push the boundaries of science to deliver life-changing medicines.